Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00416715 · ClinicalTrials.gov registry record · Phase 2
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT00416715 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 100 participants.
The verdict
NCT00416715, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
This phase II trial is studying vitamin D deficiency, muscle pain, joint pain, and joint stiffness in postmenopausal women receiving letrozole for stage I-III breast cancer. Learning about vitamin D deficiency and muscle pain, joint pain, and joint stiffness in patients receiving letrozole for breast cancer may help doctors plan treatment and may help patients live more comfortably
Interventions
- OTHER laboratory biomarker analysis
- DRUG letrozole
- DIETARY_SUPPLEMENT calcium carbonate
- DIETARY_SUPPLEMENT calcium citrate
- DIETARY_SUPPLEMENT calcium glucarate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00416715
The ClinicalTrials.gov registry entry for NCT00416715 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00416715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00416715 about?
NCT00416715 is a clinical study titled "Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer". This phase II trial is studying vitamin D deficiency, muscle pain, joint pain, and joint stiffness in postmenopausal women receiving letrozole for stage I-III breast cancer. Learning about vitamin D deficiency and muscle pain, joint pain, and joint stiffness in patients receiving letrozole for breas...
What is the current status of trial NCT00416715?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2006-10. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00416715?
The interventions under investigation include: laboratory biomarker analysis (OTHER), letrozole (DRUG), calcium carbonate (DIETARY_SUPPLEMENT), calcium citrate (DIETARY_SUPPLEMENT), calcium glucarate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00416715?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.